An international observational prospective study to determine the cost of asthma exacerbations (COAX).
about
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and childrenIncreased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and childrenAsthma exacerbations . 1: epidemiologyIncreased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and childrenThe Danish National Database for Asthma: establishing clinical quality indicatorsDetection of exacerbations in asthma based on electronic diary data: results from the 1-year prospective BIOAIR study.Can asthma control be improved by understanding the patient's perspective?Characterization of patients who suffer asthma exacerbations using data extracted from electronic medical records.Identification and management of adults with asthma prone to exacerbations: can we do better?Economic burden of asthma: a systematic reviewManaging the pediatric patient with refractory asthma: a multidisciplinary approach.Azithromycin augments rhinovirus-induced IFNβ via cytosolic MDA5 in experimental models of asthma exacerbation.Acupuncture for asthma: Protocol for a systematic reviewThe impact of adherence and disease control on resource use and charges in patients with mild asthma managed on inhaled corticosteroid agents.Structuring and validating a cost-effectiveness model of primary asthma prevention amongst children.The role of tiotropium in the management of asthma.Co-morbid psychological dysfunction is associated with a higher risk of asthma exacerbations: a systematic review and meta-analysis.Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working GroupResearch needs in allergy: an EAACI position paper, in collaboration with EFA.Failure to refill essential prescription medications for asthma among pediatric Medicaid beneficiaries with persistent asthmaAn evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.The Clinical and Health Economic Value of Clinical Laboratory DiagnosticsAn official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.Personalising care of adults with asthma from Asia: a modified e-Dephi consensus study to inform management tailored to attitude and control profiles.Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients.Cost-Effectiveness Analysis of Omalizumab for the Treatment of Severe Persistent Asthma in Real Clinical Practice in Spain.Predictors of future exacerbation risk in patients with asthma.Development of allergic immunity in early life.Relationship between asthma control status, the Asthma Control Test™ and urgent health-care utilization in Asia.Associations between pollen counts, pollutants, and asthma-related hospital admissions in a high-density Indian metropolis.Preventing Severe Asthma Exacerbations in Children. A Randomized Trial of Mite-Impermeable Bedcovers.The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study.Sources of variation in the costs of health care for asthma patients in Australia.Omalizumab Is Associated with Reduced Acute Severity of Rhinovirus-triggered Asthma Exacerbation.Association of exercise-induced wheeze and other asthma symptoms with emergency department visits and hospitalizations in a large cohort of urban adolescents.Cost effectiveness of tiotropium in patients with asthma poorly controlled on inhaled glucocorticosteroids and long-acting β-agonists.
P2860
Q24234439-102F709D-62A5-475E-BAB5-586DC0DEE373Q24235793-24D9188B-7EA5-4492-861F-CF2E390F40C7Q24683608-437D53B7-BD88-4433-9990-C7B5FFFE2157Q26471520-36FE165D-F16A-4DA5-8466-05D929E61E53Q28074257-02522232-64EB-4854-AFA4-8B2672260127Q30613061-C781416F-297A-48B5-911D-EA8659C473FDQ30831813-39BFF4BF-2B29-45CB-B9A0-DDDFC066758EQ33383532-8BEEF98D-5A97-4CF8-9EC4-641A239089D0Q33396567-E01E555D-2242-4AB3-8022-7FD06570F995Q33447966-3B73DAEB-0421-4811-A6EE-612113AB129BQ33602567-7AFADCA5-8B12-47F0-B972-03FC0420E678Q33761836-23B8379C-16B0-48C3-9E7B-0450276FA7F2Q33879735-85978979-4A38-4084-8C38-3539BDA8903DQ33966122-A9B742EF-4B72-4D90-89E1-834CC6A9F51FQ34070852-801ED129-E395-4B15-A737-6B6156CE7448Q35937096-293308DD-8C48-4EFF-AF9A-85F85099E539Q36050035-2E39AE8F-C80E-48B7-AC08-97F13EB35AE3Q36364500-90C3ACF6-7563-4144-B31B-4AFD26A0C944Q36517533-8929752A-F2B9-4730-8D3C-B315B9FAA4F0Q36538855-5B0711CD-6D0B-4362-BC83-0AF50525E7B3Q37150465-8CCEF7F8-E0C2-488B-9EF5-B2E6C91DBD8DQ37155167-3E60FF0A-E0CE-4A44-BB53-1399CC56BE0EQ37522916-D855CAD6-6C1E-4872-8035-D61C1141F04DQ37560160-13C62A83-F760-4BF7-BC18-6669DA1A6594Q38114967-872792F8-409A-410F-AF4B-C29F5CC6853EQ38824499-443148F7-7F18-4EB1-975F-FBA6CE4F4810Q38834113-0C345712-06E2-40E1-BECB-41729D285994Q39402872-D3EFEF17-F315-4557-AFEA-90004DC8AABFQ39973102-E84C4B17-0DB9-4DC0-84C3-DEC964E46C6CQ40062865-9FEEB1EC-3EB6-468A-BFCD-8114131BD7E9Q40297916-31D783CB-8803-4858-82D6-03C3C19EBA92Q41577766-4A65521A-95FA-4132-823F-97AE699B39BCQ43743949-9E118F48-4212-465A-A3D2-70D4EF606922Q45898148-271C31CD-3AB9-4718-82AF-73623B77C92AQ50135266-FDF9880B-7FBB-4953-B70C-EF4A659944B3Q51713924-A18A2A43-748A-44A2-A647-7C5FF1663CB9
P2860
An international observational prospective study to determine the cost of asthma exacerbations (COAX).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
An international observational ...... f asthma exacerbations (COAX).
@en
An international observational ...... e cost of asthma exacerbations
@nl
type
label
An international observational ...... f asthma exacerbations (COAX).
@en
An international observational ...... e cost of asthma exacerbations
@nl
prefLabel
An international observational ...... f asthma exacerbations (COAX).
@en
An international observational ...... e cost of asthma exacerbations
@nl
P2093
P1433
P1476
An international observational ...... f asthma exacerbations (COAX).
@en
P2093
Jesus Molina
Stephen Lane
Tadeusz Plusa
P304
P356
10.1016/J.RMED.2005.06.012
P577
2005-08-11T00:00:00Z